Holm Nielsen, Signe
Port, Helena
Møller Hausgaard, Cecilie
Holm, Jesper Grønlund
Thyssen, Jacob P.
Groen, Solveig Skovlund
Karsdal, Morten
Nielsen, Valdemar Wendelboe
Egeberg, Alexander
Bay-Jensen, Anne-Christine
Thomsen, Simon Francis
Funding for this research was provided by:
Innovation Fund Denmark
Danish Research Foundation
Article History
Received: 13 October 2022
Accepted: 24 January 2023
First Online: 21 February 2023
Competing interests
: SHN, HP, CMH, MK, and ACBJ are full-time employees at Nordic Bioscience A/S. Nord 9. Nordic Bioscience is a privately-owned, small–medium-size enterprise (SME) partly focused on developing biomarkers. None of the authors received fees, bonuses, or other benefits for the work described in the manuscript. SHN, MAK, and ACBJ hold stocks in Nordic Bioscience A/S. JGH, JPT, SSG, VWN, AE and SFT have no competing interest.